Show & Tell #4: Gastrointestinal Cancers
- Watch this Show and Tell on Gastrointestinal cancers.
- Dr Andrew J. Wroe, Director of Proton Physics, and Dr Adeel Kaiser, Radiation Oncologist, will share...
Phase II Study of PBRT for Patients With Breast Cancer Requiring Regional Nodal Irradiation.
This study evaluated 70 patients among who 63 patients (91%) had left-sided breast cancer, two had bilateral breast cancer, and five had right-sided breast...
Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.
With the National Cancer Database for T1-2N0 HCC patients receiving PBT or SBRT, a total of 71 patients received PBT and 918 patients received SBRT were...
A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
There were 314 and 31 patients with single primary nodular HCC ≤ 100 mm without vessel invasion who underwent surgical resection (SR) and PBT were analyzed. The...
Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
A study by the research group in Prague. Two hundred patients with early-stage prostate cancer were treated with IMPT on extreme hypofractionated schedule (36...